LobbyingMayo Clinic lobbying by quarter
Mayo Clinic's latest lobbying report covers Q2 2026, at $410K. The four quarters Q4 2025–Q3 2026 total $1.2M. Its first report covers Q3 2022; the issues it reports most are Medicare/Medicaid and Health Issues.
Mayo Clinic
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $1.3M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2022 | $30K | 1 |
| Q4 2022 | $60K | 2 |
| Q1 2023 | $260K | 3 |
| Q2 2023 | $250K | 3 |
| Q3 2023 | $190K | 3 |
| Q4 2023 | $280K | 3 |
| Q1 2024 | $450K | 4 |
| Q2 2024 | $360K | 4 |
| Q3 2024 | $350K | 4 |
| Q4 2024 | $407.5K | 5 |
| Q1 2025 | $397.5K | 5 |
| Q2 2025 | $397.5K | 5 |
| Q3 2025 | $377.5K | 5 |
| Q4 2025 | $390K | 5 |
| Q1 2026 | $450K | 4 |
| Q2 2026 | $410K | 4 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$2.7M · 46 reports
- Health issues$2.1M · 40 reports
- Government issues$113.3K · 2 reports
- Defense$50K · 1 reports
- Copyright, patent and trademark$20K · 2 reports
- Taxation$20K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES46 reports
- SENATE46 reports
- Health & Human Services, Dept of (HHS)14 reports
- Centers For Medicare and Medicaid Services (CMS)11 reports
- Health Resources & Services Administration (HRSA)4 reports
- Executive Office of the President (EOP)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseMayo Clinic | $3.5M | 14 quarters |
| Mehlman Consulting | $780K | 16 quarters |
| Welsh Rose | $600K | 10 quarters |
| McDermott Will & Schulte | $180K | 15 quarters |
| Manatt, Phelps, and Phillips | $30K | 5 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| EARL SCOTT FLOOD | Dep. CoS, LD (Rep. Robin Kelly); Health Pol Adv, Csl (Rep. Terri Sewell); Csl (Rep. Cedric Richmond); Pol Aide (Sen. Claire McCaskill) | Q4 2025 |
| JOSEPH EDWARD BROWN iii | Sr Prof Staff (EPW Comm Maj/Sen. Moore Capito); Prof Staff (EPW Comm Min/Ranking Mem Sen. Moore Capito); Leg Asst (Sen. Boozman); Maj Leg Asst (EPW Comm Maj/Sen. Jim Inhofe); Maj Research Asst (EPW Comm Maj/Sen. Jim Inhofe); Intern (Rep. Jim Renacci) | Q3 2025 |
| NICHOLAS WILLIAM BATH jr | Health Policy Director of the U.S. Senate Committee on Health, Education, Labor and Pensions | Q3 2025 |
| JON ADAME | CoS, LD, GC (Sen. Blackburn); Counsel (Rep. Blackburn); Policy Coordinator (House E&C); Intern (Sen. Domenici) | Q2 2025 |
| ANNIE WOLF | Dep Floor Dir (Maj Leader Scalise); CoS (Chief Dep Min Whip Ferguson); Dep Floor Dir (Min Whip Scalise); Prof Staff (House Rules/Sessions); Floor Asst (Speakers Ryan & Boehner); Staff Asst (Speaker Boehner); Intern (Rep. Sullivan) | Q3 2024 |
| NAVEEN PARMAR | Chief Counsel (Sen. Hickenlooper); General Counsel (House Comm on Sm Bus/Velazquez); Tax Counsel, (House Comm on Sm Bus/Velazquez); Economic Policy Counsel (Sen. Amy Klobuchar); Ways and Means Counsel (Rep. Lloyd Doggett) | Q3 2024 |
| ALYENE MLINAR | Pol Adv (Maj Leader Scalise); Pol Adv (Min Whip Scalise); Pol Adv (House Oversight/Govt Reform Comm); Prof Staff Member (Ways and Means Subcom on Health/Brady), Pol Adv (Sen Rep Policy Comm/Barrasso); Leg Asst (Senator Ben Sasse) | Q1 2024 |
| ERICA JAY CHABOT | Staff Asst, Leg Corres, Asst Schd, Asst to COS, Press Asst, Dep Press Sec, Leg Dir (Senator Patrick Leahy); Prof Staff (Sen Approp Comm); LD (Sen Pres Pro Temp Emeritus); Dep COS (Senate Consult); Staff Dir (Sen Ag Comm) | Q1 2024 |
| DEBRA CURTIS | 1998-2013: Legislative Director, Chief of Staff, Rep. Pete Stark; jointly Professional Staff on Committee on Ways and Means, Health Subcommittee | Q3 2023 |
| RODNEY WHITLOCK | 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood | Q3 2023 |
| CAITLIN VAN SANT | Sr Pol Adv, Leg Dir, Interim COS (Rep. Butterfield) | Q4 2022 |
| LISA GOLDMAN | Sr Counsel, House Comm on Energy & Commerce; Chief Counsel, Sr Counsel (E&C Subcommittee on Consumer Protection & Commerce); Counsel House Comm on E&C | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $290K |
| 07/17for Q2 | Mehlman Consulting | $60K |
| 07/09for Q2 | McDermott Will & Schulte | Under $5,000 |
| 07/08for Q2 | Welsh Rose | $60K |
| 04/20for Q1 | In-house | $330K |
| 04/17for Q1 | Mehlman Consulting | $60K |
| 04/13for Q1 | McDermott Will & Schulte | Under $5,000 |
| 04/08for Q1 | Welsh Rose | $60K |
| 01/20for Q4 2025 | Manatt, Phelps, and Phillips | Under $5,000 |
| 01/20for Q4 2025 | In-house | $270K |
| 01/16for Q4 2025 | Welsh Rose | $60K |
| 01/16for Q4 2025 | Mehlman Consulting | $60K |
| 01/09for Q4 2025 | McDermott Will & Schulte | Under $5,000 |
| 25/10/20for Q3 2025 | Welsh Rose | $60K |
| 25/10/17for Q3 2025 | Mehlman Consulting | $60K |
| 25/10/16for Q3 2025 | In-house | $250K |
| 25/10/16for Q3 2025 | Manatt, Phelps, and Phillips | $7,500 |
| 25/10/08for Q3 2025 | McDermott Will & Schulte | Under $5,000 |
| 25/07/18for Q2 2025 | In-house | $270K |
| 25/07/18for Q2 2025 | Mehlman Consulting | $60K |